Wells Fargo’s Comeback Is Real—But Not Risk-Free

Why It Matters

Lifting the asset cap signals regulatory confidence, allowing Wells Fargo to expand lending and reward investors, but margin compression and higher credit provisions could temper the rebound. The mix of growth and risk factors will shape the bank’s competitive position and valuation in a tightening rate environment.

Key Takeaways

• Q1 net income $5.3 B, beating expectations.
• Asset cap removal spurred 13% asset growth to $2.17 T.
• $4 B share buyback and 45¢ dividend signal confidence.
• Credit loss provision rose 22% to $1.1 B.
• Net‑interest margin fell 20 bps, pressuring earnings.

Pulse Analysis

The Federal Reserve’s decision to lift the $1.95 trillion asset cap on Wells Fargo marks a rare regulatory reset for a major U.S. bank. Imposed after the 2016 scandal over unauthorized accounts, the cap limited balance‑sheet expansion for nearly a decade. Its removal this year reflects the bank’s extensive remediation efforts and signals to investors that supervisory concerns have eased, opening the door for more aggressive loan origination and deposit gathering.

Financially, the quarter showcased the first tangible benefits of that regulatory freedom. Assets climbed to $2.17 trillion, a 13% year‑over‑year rise, while loan growth accelerated to 11% and deposits rose 7%. Net interest income grew 5% despite a 20‑basis‑point margin squeeze, and non‑interest revenue jumped 8% to $9.4 billion. Shareholder‑return initiatives intensified, with a $4 billion share repurchase program and a 45‑cent dividend that lifts the yield above 2%, reinforcing confidence in capital adequacy after the redemption of $3.5 billion in preferred stock.

Nevertheless, the comeback is not without headwinds. The provision for credit losses surged 22% to $1.1 billion, suggesting the bank is bracing for potential loan delinquencies as interest rates remain elevated. Net‑interest margin pressure could intensify if the Fed sustains a tighter policy stance, forcing the bank to rely more on fee‑based income. Analysts project a 12‑month price target near $97, implying roughly 27% upside, but the stock already trades at about 12‑times trailing earnings with a modest dividend yield. For patient investors, the valuation may offer a balanced risk‑reward profile, provided credit quality stabilizes and margin compression eases.